The CD47/SIRPα interaction is another therapeutic target for human solid tumors: CD47 is a unique cell-surface marker expressed by human cancers; SIRPα is a protein expressed on macrophages and dendritic cells [15,16,24]. The gene discussed is SIRPA; the disease is cancer.